trial

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

NCTId NCT00148083
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 5 (actual)
Sponsored by University of Illinois at Chicago
Primary completion 2006-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
5 (actual)
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
Single
Start
2005-09
Primary completion
2006-03
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
RisperidoneSocial Skills Training

Sponsors

University of Illinois at ChicagoLead Sponsor
Janssen, L.P. - Investigator Initiated Studies ProgramCollaborator
Weill Medical College of Cornell UniversityCollaborator

Investigators

1
Steven M Silverstein, Ph.D.Principal Investigator

Sites

2 total
Chicago, United StatesWhite Plains, United States

Linked catalysts

1
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in — primary completion2006-03

Facts & assertions

4 sourced
Enrollment
5
Phase
PHASE3
Primary Completion Date
2006-03
Status
COMPLETED
relationships
The graph out of here
drug
Risperidone
drug
Social Skills Training
drug
lead_sponsor
University of Illinois at Chicago
company
collaborator
Janssen, L.P. - Investigator Initiated Studies Program
company
Weill Medical College of Cornell University
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Steven M Silverstein, Ph.D.
person